Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV

Abstract Hepatic steatosis (HS) related to nonalcoholic fatty liver disease (NAFLD) is increasing globally. In people living with human immunodeficiency virus (PLWH) risk factors of HS are increased. The impact of HS on outcomes and in particular health‐related quality of life (HRQL) in PLWH remains...

Full description

Bibliographic Details
Main Authors:	Maurice Michel, Christian Labenz, Malena Anders, Alisha Wahl, Lisann Girolstein, Leonard Kaps, Wolfgang M. Kremer, Yvonne Huber, Peter R. Galle, Martin Sprinzl, Jörn M. Schattenberg
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2022-08-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1958

Similar Items

Metabolic dysfunction-associated fatty liver disease in people living with HIV
by: Maurice Michel, et al.
Published: (2023-06-01)

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
by: Simon Johannes Gairing, et al.
Published: (2022-05-01)

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
by: Christian Labenz, et al.
Published: (2020-09-01)

Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
by: Maurice Michel, et al.
Published: (2021-10-01)

Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
by: Wolfgang Maximilian Kremer, et al.
Published: (2022-09-01)

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
by: Leonard Kaps, et al.
Published: (2022-04-01)

Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis
by: Leonard Kaps, et al.
Published: (2023-01-01)

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol
by: Christian Labenz, et al.
Published: (2019-11-01)

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
by: Simon Johannes Gairing, et al.
Published: (2023-04-01)

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders
by: Simon Johannes Gairing, et al.
Published: (2021-12-01)

Portal vein thrombosis is associated with an increased risk of bone fractures.
by: Simon Johannes Gairing, et al.
Published: (2022-01-01)

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
by: Leonard Kaps, et al.
Published: (2020-12-01)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
by: Leonard Kaps, et al.
Published: (2022-05-01)

Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
by: Leonard Kaps, et al.
Published: (2022-12-01)

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
by: Michael Nagel, et al.
Published: (2022-02-01)

The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
by: Maurice Michel, et al.
Published: (2021-05-01)

Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry
by: Monika Rau, et al.
Published: (2022-01-01)

Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry.
by: Monika Rau, et al.
Published: (2022-01-01)

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B
by: Martin F. Sprinzl, et al.
Published: (2021-08-01)

Incidental Hepatic Steatosis
by: Lawrence S. Friedman, et al.
Published: (2023-01-01)

Recognition of Diffuse Hepatic Steatosis
by: Danil Yevdokimov, et al.
Published: (2023-05-01)

Iron, hepatitis C virus and hepatic steatosis
by: J. A. Solís Herruzo, et al.

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
by: Michael Nagel, et al.
Published: (2023-04-01)

A higher FIB‐4 index is associated with an increased incidence of renal failure in the general population
by: Eva Maria Schleicher, et al.
Published: (2022-12-01)

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives
by: Michael Nagel, et al.
Published: (2020-01-01)

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
by: L Kaps, et al.
Published: (2021-01-01)

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study
by: Wolfgang M. Kremer, et al.
Published: (2022-02-01)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
Published: (2006-04-01)

Hepatic steatosis and its relationship to transplantation.
by: Imber, C, et al.
Published: (2002)

Grading of Hepatic Steatosis by Ultrasound Quantification
by: Elaheh Askari Moghadam
Published: (2023-02-01)

Recent Advances in the Assessment of Hepatic Steatosis
by: V.I. Didenko
Published: (2015-09-01)

Genetic determinants of hepatic steatosis in man
by: Amanda J. Hooper, et al.
Published: (2011-04-01)

Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis?
by: Yu.M. Stepanov, et al.
Published: (2013-04-01)

The impact of hepatic steatosis on portal hypertension.
by: Georg Semmler, et al.
Published: (2019-01-01)

The Associations of Anthropometric Parameters and Hepatic Steatosis
by: Maryam Ghandehari, et al.
Published: (2020-03-01)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
by: Venu Gopala Reddy Gangireddy, et al.
Published: (2022-03-01)

Risk Factors for Hepatic Steatosis in Children
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

Advanced fibrosis leads to overestimation of steatosis with quantitative ultrasound in individuals without hepatic steatosis
by: Takashi Kumada, et al.
Published: (2024-03-01)

Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis
by: Jessica Seeßle, et al.
Published: (2020-07-01)

Variability of transient elastography-based spleen stiffness performed at 100 Hz
by: Angelo Armandi, et al.
Published: (2023-12-01)